Detalles de la búsqueda
1.
An Organoid Biobank of Neuroendocrine Neoplasms Enables Genotype-Phenotype Mapping.
Cell;
183(5): 1420-1435.e21, 2020 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159857
2.
Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors: A Retrospective Analysis.
Oncologist;
29(1): e108-e117, 2024 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37590388
3.
Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study).
Br J Cancer;
129(6): 1032-1039, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37532830
4.
Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: a multicenter retrospective study.
BMC Cancer;
23(1): 283, 2023 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36978040
5.
Distribution of Residual Disease and Recurrence Patterns in Pathological Responders After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Ann Surg;
276(2): 298-304, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33074909
6.
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study.
Gastric Cancer;
25(1): 207-217, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34480657
7.
Management of elderly patients with esophageal squamous cell cancer.
Jpn J Clin Oncol;
52(8): 816-824, 2022 08 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35511482
8.
[A Survey on the Care of Patients with Cancer during the COVID-19 Pandemic].
Gan To Kagaku Ryoho;
49(8): 867-871, 2022 Aug.
Artículo
en Japonés
| MEDLINE | ID: mdl-36046972
9.
Prospective evaluation and refinement of an S-1 dosage formula based on renal function for clinical application.
Cancer Sci;
112(2): 751-759, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33277781
10.
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab.
Gastric Cancer;
24(4): 946-958, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33743112
11.
Analysis of risk factors for immune-related adverse events in various solid tumors using real-world data.
Future Oncol;
17(20): 2593-2603, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33878916
12.
A management of neutropenia using granulocyte colony stimulating factor support for chemotherapy consisted of docetaxel, cisplatin and 5-fluorouracil in patients with oesophageal squamous cell carcinoma.
Jpn J Clin Oncol;
51(2): 199-204, 2021 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33147611
13.
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07).
Esophagus;
18(4): 835-843, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33993388
14.
Nivolumab versus chemotherapy in Japanese patients with advanced esophageal squamous cell carcinoma: a subgroup analysis of a multicenter, randomized, open-label, phase 3 trial (ATTRACTION-3).
Esophagus;
18(1): 90-99, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33170461
15.
Long-term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancer.
Cancer Sci;
111(5): 1676-1684, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32160365
16.
A 3-Year Overall Survival Update From a Phase 2 Study of Chemoselection With DCF and Subsequent Conversion Surgery for Locally Advanced Unresectable Esophageal Cancer.
Ann Surg Oncol;
27(2): 460-467, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31376034
17.
Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
BMC Cancer;
20(1): 548, 2020 Jun 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32532230
18.
Achieving sequential therapy in advanced gastric cancer: the importance of appropriate patient management for the elderly and/or those with ascites.
Gastric Cancer;
23(3): 363-372, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32236760
19.
Exploratory subgroup analysis of patients with prior trastuzumab use in the ATTRACTION-2 trial: a randomized phase III clinical trial investigating the efficacy and safety of nivolumab in patients with advanced gastric/gastroesophageal junction cancer.
Gastric Cancer;
23(1): 143-153, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31087200
20.
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Gastric Cancer;
23(3): 510-519, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31863227